Candesartan cilexetil
- Molecular formula
- C33H34N6O6
- CAS Number
- 145040-37-5
- IUPAC Name
- 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- Molecular Weight
- 610.66g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3600g/cm3
- Synonyms
- Candesartan cilexetil
Identification
Interesting Facts about 1-(Cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
This compound, often referred to in scientific discussions as a specialized organic molecule, showcases an intricate structure that is a fusion of various chemical functionalities. Here are some compelling points regarding this compound:
- Diverse Functional Groups: This molecule features an array of functional groups, including ethoxy, carbonyloxy, and tetrazole, which all contribute to its unique chemical behavior and potential applications in medicinal chemistry.
- Pharmacological Potential: The presence of the tetrazole ring has been linked to various biological activities, making this compound a subject of interest in drug discovery processes. Tetrazoles are often used in the development of pharmaceuticals due to their ability to enhance bioavailability.
- Synergistic Interactions: The combination of the benzimidazole core with other aromatic systems may result in synergistic effects that could modify the compound's efficacy in biological contexts, potentially impacting its pharmacodynamics and pharmacokinetics.
Researchers are continually interested in exploring the intricate interactions of such compounds, especially in fields such as:
- Medicinal Chemistry
- Drug Design and Development
- Agricultural Chemistry
As stated by renowned chemist Robert H. Grubbs, “The best way to prepare for the future is to invent it.” This sentiment resonates with the exploration of complex molecules like this one, which hold promise for fostering innovation in therapy and treatment methodologies.
Continued investigation into the biological activities and synthesis routes of compounds like 1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate may unlock potential breakthroughs in the pharmaceutical sector.